Tissue engineering of heart valves: Formation of a three-dimensional tissue using porcine heart valve cells

ASAIO Journal

Volumn 48, Issue 6, 2002, Pages 586-591

  Rothenburger, Markus ^a   Völker, Wolfgang ^a   Vischer, Peter ^a   Berendes, Elmar ^a   Glasmacher, Birgit ^a   Scheld, Hans Heinrich ^a   Deiwick, Michael ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMEDICAL ENGINEERING; CELLS; COLLAGEN; MORPHOLOGY; SURFACE TOPOGRAPHY; TISSUE;

ELECTRON MICROGRAPHS; HEART VALVES;

CARDIOVASCULAR SYSTEM;

CHONDROITIN SULFATE; COLLAGEN FIBRIL; DERMATAN SULFATE; HEPARAN SULFATE; PROTEOGLYCAN; SULFATE; SULFUR 35; COLLAGEN; SCLEROPROTEIN;

ANIMAL CELL; ARTICLE; ELECTRON MICROSCOPY; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; HEART VALVE; HISTOLOGY; ISOTOPE LABELING; MYOFIBROBLAST; NONHUMAN; SWINE; THORACIC AORTA; TISSUE ENGINEERING; ANIMAL; CHEMISTRY; CYTOLOGY; FIBROBLAST; ULTRASTRUCTURE; VASCULAR ENDOTHELIUM;

ANIMALS; AORTA, THORACIC; COLLAGEN; ENDOTHELIUM, VASCULAR; EXTRACELLULAR MATRIX; EXTRACELLULAR MATRIX PROTEINS; FIBROBLASTS; HEART VALVES; MICROSCOPY, ELECTRON; PROTEOGLYCANS; SWINE; TISSUE ENGINEERING;

EID: 0036841943     PISSN: 10582916     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002480-200211000-00003     Document Type: Article

References (23)

1. Shinoka T, Imai Y, Ikada Y: Transplantation of a tissue-engineered pulmonary artery. N Engl J Med 344: 532-533, 2001.
2. Vonpatanasin W, Hillis D, Lange RA: Prosthetic heart valves. N Engl J Med 335: 407-416, 1996.
3. Cannegieter SC, Rosendaal FR, Briet E: Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses. Circulation 89: 635-641, 1994.
4. Shoen FJ, Mitchell RN, Jonas RA: Pathological considerations in cryopreserved allograft heart valves. J Heart Valve Dis 4: 72-76, 1995.
5. Nanda N, Helmcke FR, Bourge RC: Long-term function of cryo-preserved aortic homografts. J Thorac Cardiovasc Surg 106: 154-166, 1993.
6. Yacoup M, Rasmi NR, Sundt TM, et al: Fourteen year experience with homovital homografts for aortic valve replacement. J Thorac Cardiovasc Surg 100: 186-193, 1995.
7. Shinoka T, Breuer CK, Tanel RE, et al: Tissue engineering heart valves: Valve leaflet replacement study in a lamb model. Ann Thorac Surg 60(Suppl): S513-S516, 1995.
8. Shinoka T, Ma PX, Shum-Tum D, et al: Tissue-engineered heart valves. Autologous valve leaflet replacement study in a lamb model. Circulation 94(Suppl 2): 164-168, 1996.
9. Sodian R, Hoerstrup SP, Sperling JS, et al: Early in vivo experience with tissue-engineered trileaflet heart valves. Circulation 102 (Suppl 3): 22-29, 2000.
10. Stock UA, Nagashima M, Khalil PN, et al: Tissue-engineered valve conduits in the pulmonary circulation. J Thorac Cardiovasc Surg 119: 732-740, 2000.
11. Steinhoff G, Stock U, Karim N, et al: Tissue engineering of pulmonary heart valves on allogenic acellular matrix conduits. Circulation 102 (Suppl 3): 50-55, 2000.
12. Rothenburger M, Vischer P, Völker W, et al: In vitro modeling of tissue using isolated vascular cells on a synthetic collagen matrix as substitute for heart valves. J Thorac Cardiovasc Surg 49: 204-209, 2001.
13. Zund G, Breuer CK, Shinoka T, et al: The in vitro construction of a tissue engineered bioprosthetic heart valve. Eur J Cardiothorac Surg 11: 493-497, 1997.
14. Schoof H, Bruns L, Apel J, Heschel I, Rau G: Einfluß des einfriervorgangs auf die porenstruktur gefriergetrockneter kollagenschwämme. DKV-Berichte 1997: 24. Jahrgang Band III: pp. 40-57.
15. Vischer P, Buddecke E: Alteration of glycosyltransferase activities during proliferation of cultivated arterial endothelial cells and smooth muscle cells. Exp Cell Res 158: 15-28, 1985.
16. Vischer P, Feitsma K, Schön P, Völker W: Perlecan is responsible for thrombospondin 1 binding on the cell surface of cultured porcine endothelial cells. Eur J Cell Biol 73: 332-343, 1997.
17. Völker W: Cytochemical characterization and mapping of glycoconjugates in arterial tissues and vascular cell cultures by light and electron microscopy, in Robenek H, Severs NJ (eds), Cell Interactions in Atherosclerosis. Boca Raton: CRC, 1992, pp. 181-206.
18. Völker W, Schmidt A, Oortmann W, Broszey T, Faber V, Buddecke E: Mapping of proteoglycans in atherosclerotic lesions. Eur Heart J 11: 29-40, 1990.
19. Scott JE: Morphometry of cupromeronic blue-stained proteoglycan molecules in animal corneas versus that of purified proteoglycans stained in vitro, implies that tertiary structures contribute to corneal ultrastructure. J Anat 180: 155-164, 1992.
20. Cheresh DA, Berliner SA, Vincente V, et al: Recognition of distinct adhesive sites on fibrinogen by related integrins on platelets and endothelial cells. Cell 58: 945-953, 1989.
21. Joshi P, Chung CY, Aukhil I, et al: Endothelial cells adhere to the RGD domain and the fibrinogen-like terminal knob of tenascin. J Cell Science 106: 389-400, 1993.
22. Völker W, Schmidt A, Buddecke E: Compartmentation and characterization of different proteoglycans in bovine arterial wall. J Histochem Cytochem 34: 1293-1299, 1986.
23. Bernfield M, Götte M, Park PW, et al: Function of cell surface heparan sulfate proteoglycans. Ann Rev Biochem 68: 729-777, 1999.